NCT02103725View on ClinicalTrials.gov

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Atopic Dermatitis
Interventions
DRUG

pimecrolimus 10 mg/g cream

DRUG

Vehicle cream

Trial Locations (1)

20095

bioskin GmbH, Hamburg

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT02103725 - A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis | Biotech Hunter | Biotech Hunter